In 1915 Hans Fischer identified the kinds and types of porphyrins excreted in congenital porphyria (1, 2, 3) , and since that time 8 cases of this rare disease have been studied by qualitative, chemical methods (4 to 11) . No quantitative studies of the total excretion of porphyrins in this condition have been made, however, and although reports of the therapeutic effect of liver extract on acute porphyria are recorded in the literature (12, 13, 14) , complete detailed observations have not been published. In this communication qualitative studies of the types and kinds of porphyrins excreted in 3 cases of congenital porphyria are recorded, together with quantitative studies of the coproporphyrin excretion and the effect of liver extract therapy on that excretion in 2 of the cases.
The methods used for the qualitative and quantitative determinations of the urinary and fecal porphyrins, except uroporphyrin, are those previously reported (15, 16) . Uroporphyrin was isolated by the method of Fischer and Duesberg (11) , but because of the lack of a suitable method it was not measured quantitatively. In all instances a thorough search for isomeric and hitherto undescribed porphyrins was made.
The dinical material studied was as follows: Case I (Rochester) (20) . A clinical report has been published (29) . Case II (Baltimore), Hospital record number 98673, Harriet Lane Home, Johns Hopkins Hospital. Case III (San Francisco). A preliminary report concerning the photosensitivity in this child has already been published by Blum and Hardgrave (17) .
RESULTS

Qualitative
In all 3 cases both coproporphyrin and uroporphyrin were present in large amounts in the urine. Much coproporphyrin was present in the feces, as well as relatively small amounts of protoporphyrin and deuteroporphyrin. In Table I the results of the melting point determinations are given. In Case I relatively large amounts of a natural coproporphyrin ester (15b) were present both in the urine and in the feces, but it was not found constantly. This natural ester had an HCI number of 0.3 to 0.5 per cent HCI, and was easily extracted from this HCI concentration with chloroform. It could be saponified with 20 per cent NaOH. After saponification the porphyrin was no longer soluble in chloroform and showed all the properties of coproporphyrin. Spectroscopically it was identical with coproporphyrin. Although the esterifying group could not be established definitely, certain qualities suggested that it was of a lipoidal nature. The Liebermann-Burchard reaction was negative. After saponification the porphyrin was esterified and the methyl ester was identified by melting point determinations as coproporphyrin I (M. P.
C.). Quantitative
In Cases I and II quantitative determinations of coproporphyrin excretion in the urine and feces could be made during control periods and during periods of intensive intramuscular liver extract therapy.
Case I (Rochester) Figure 1 . August, 1936 , and was maintained on a meat free diet during the study. Quantitative studies of coproporphyrin were made both of the urine and feces on 3-day collections. A control period of 6 days was followed by a period of 11 days, during which 5 cc. of concentrated liver extract (Eli Lilly and and Co.) was injected intramuscularly each day. In a subsequent period of 12 days, 5 cc. of liver extract was administered twice weekly, and in a final period of 18 days 10 to 30 grams of liver extract (Lilly) was administered daily by mouth.
The total excretion of coproporphyrin during the control period was about 50 times the normal average for a child. The average daily total output was 9380 micrograms, of which 870 micrograms were excreted in the urine. Following daily injections of liver extract the total coproporphyrin output decreased to an average of 4450 micrograms a day, of which 550 micrograms were in the urine. In the third period the excretion of coproporphyrin increased rapidly, approaching the levels present before treatment. The total coproporphyrin output during this period averaged 9250 micrograms, of which 1060 micrograms were excreted in the urine. In a fourth period, of 18 days' duration, the patient received from 10 to 30 grams daily of liver extract by mouth, and 2 injections of intramuscular liver extract weekly. The coproporphyrin output in this period averaged 8890 micrograms of which 1240 micrograms were excreted in the urine. During the period of intensive liver extract therapy the uroporphyrin excretion decreased, and the natural porphyrin ester excreted during the control period could no longer be detected. Clinical improvement was manifested by the disappearance of the vesicular eruption.
Case II (Baltimore) Figure 2 . The patient was a 4-year-old girl observed from 1936 to 1938 in the Harriet Lane Home and maintained on a constant diet. The urine and feces were collected in 3-day periods and studied at the Hospital of the Rockefeller Institute. In the control period of 15 days the child excreted an average of 5600 micrograms of coproporphyrin daily, of which 1535 micrograms were excreted in the urine. In the treatment period of 12 days the patient received 5 cc. of liver extract (Lederle) intramuscularly each day. The total coproporphyrin excretion decreased to 1650 micrograms daily, of which 520 micrograms were in the urine. In a second control period of 12 days the total average coproporphyrin output rose to 6030 micrograms daily, of which 1670 micrograms were in the urine.
DISCUSSION
The 3 cases reported showed a mass excretion of coproporphyrin I and uroporphyrin I similar to the 6 cases of congenital porphyria previously described in the literature (1 to 8). Two cases of congenital porphyria with a mass excretion of coproporphyrin III also have been described elsewhere (9, 10, 11). Fischer and Hofmann (18) recently reported that in a restudy of the uroporphyrin fraction of the famous case, Petry, small amounts of uroporphyrin III were isolated from the large uroporphyrin I fraction. (25, 26) . From these studies, together with those previously reported, it appears that the disturbance of porphyrin metabolism which characterizes congenital porphyria is quite unlike that seen in pernicious anemia (23) , in pellagra (27) , or in refractory anemia (28 
